This study is looking at how well a device called the BiWaze Clear System works for people with bronchiectasis (a lung condition where airways are damaged and widened). The BiWaze Clear System helps loosen and move mucus, expand the lungs, and can deliver oxygen. If you join, you would use the BiWaze Clear System for your airway clearance therapy instead of your usual treatment. The study wants to see if using this system reduces how often you have pulmonary exacerbations (flare-ups of your lung condition) and improves your overall health. To be eligible, you must be over 5 years old and have had at least one respiratory exacerbation in the past 6 months or two in the past year. The study plans to enroll 85 participants, but its current status is unclear.

Study design

This is an interventional study involving 85 participants aged 5 and older. It will evaluate the BiWaze Clear System over a 6-month period.

What's involved

You would use the BiWaze Clear System for airway clearance therapy as prescribed for 6 months. This involves using a disposable breathing circuit.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome is measured at 6 months, which is the duration of the treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.